| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.7B | $28.1B | $28.8B | $31.5B | $27.0B | $9.1B | $2.2B | $2.0B |
| Cost of Revenue | — | — | — | — | — | $6.5B | $7.3B | $7.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $2.6B | $2.0B | $2.0B | $1.2B | $1.3B | $0.9B | $0.8B | $0.8B |
| Operating Income | $1.8B | $2.4B | $0.4B | $2.0B | $3.3B | $1.1B | $0.2B | $0.0B |
| Net Income | $0.9B | $1.1B | $-0.2B | $1.2B | $2.2B | $0.5B | $4.4B | $0.3B |
| EPS (Basic) | $4.09 | $5.14 | $-1.12 | $5.17 | $8.93 | $2.08 | $13.48 | $-0.04 |
| EPS (Diluted) | $4.01 | $4.99 | $-1.12 | $5.17 | $8.93 | $2.07 | $13.37 | $-0.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.1B | $24.0B | $26.0B | $29.1B | $23.2B | $14.9B | $12.5B | $10.6B |
| Current Assets | $13.1B | $9.0B | $9.7B | $16.2B | $10.8B | $6.0B | $3.1B | $3.6B |
| Cash & Equivalents | $4.7B | $1.0B | $0.5B | $0.4B | $0.3B | $3.9B | $0.3B | $0.6B |
| Total Liabilities | $27.5B | $21.5B | $23.1B | $25.3B | $19.6B | $13.2B | $10.9B | $11.8B |
| Current Liabilities | $8.0B | $8.8B | $9.5B | $13.0B | $7.9B | $1.9B | $2.4B | $2.4B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $2.3B | $-0.2B | $0.4B | $0.5B | $1.8B | $1.4B | $1.4B |
| Investing Cash Flow | $-1.6B | $-0.0B | $-0.9B | $-0.3B | $-3.0B | $-0.5B | $0.6B | $-0.2B |
| Capital Expenditures | $1.1B | $0.5B | $0.6B | $0.4B | $0.3B | $0.2B | $0.2B | $0.4B |
| Financing Cash Flow | $3.5B | $-1.8B | $-0.4B | $1.0B | $-0.3B | $2.2B | $-2.1B | $-1.5B |